Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators
Clinical trial NCT04732910 · RECRUITING
Trial details
- NCT number
- NCT04732910
- Sponsor
- Charite University, Berlin, Germany
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-01
- Primary completion
- 2027-03-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.